Neurosoft Bioelectronics
PrivateLast Round
Seed
May 20, 2026
Total Funding Raised
$10.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neurosoft Bioelectronics operates in Healthcare & Life Sciences and is based in Geneva. Its latest recorded funding round was a Seed round in May 2026.
Neurosoft Bioelectronics is a neurotechnology company that develops and manufactures soft, elastic, and minimally invasive brain-computer interfaces (BCIs) and neural implants to monitor, treat, and restore neurological functions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosoft Bioelectronics Comparables
Compare Neurosoft Bioelectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axoft | 88% | |
| WISE | 86% | |
| INBRAIN Neuroelectronics | 85% |
For institutional investors. Book with your work email.
Neurosoft Bioelectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2026 | ||||
| Grant | Apr 5, 2022 | ||||
| Convertible Debt | Dec 17, 2021 | ||||
| Grant | Jan 28, 2021 | ||||
| Grant | Feb 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neurosoft Bioelectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Connecticut Innovations | Seed |
| PL Capital | Seed |
| IAG Capital Partners | Seed |
| Swiss National Science Foundation | Grant |
| European Research Council | Grant |
| Skybound Venture Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 33% QoQ, from 18 to 24 employees.
- Jul 25, 2026
Monthly visitors grew 62% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 28, 2026
Neurosoft Bioelectronics SA partners with Mila, a Canada-based AI research institute, to develop AI-powered brain-computer interfaces (BCIs) for patients with severe neurological conditions in Switzerland.
For institutional investors. Book with your work email.
Neurosoft Bioelectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurosoft Bioelectronics's valuation, stock price, and market status.
Is Neurosoft Bioelectronics a public or private company?
Neurosoft Bioelectronics is a private company.
What is the current stock price of Neurosoft Bioelectronics?
Neurosoft Bioelectronics is a private company, so its shares have no public market price. Caplight tracks Neurosoft Bioelectronics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurosoft Bioelectronics worth (valuation)?
Valuation information for Neurosoft Bioelectronics is not publicly available.
Can I buy Neurosoft Bioelectronics stock?
Neurosoft Bioelectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurosoft Bioelectronics's last funding round?
Neurosoft Bioelectronics's most recent funding round was Seed on May 20, 2026.
Who are the main investors in Neurosoft Bioelectronics?
Key investors in Neurosoft Bioelectronics include Skybound Venture Capital.
Will Neurosoft Bioelectronics IPO soon?
No public IPO plans have been announced for Neurosoft Bioelectronics.
How can I track Neurosoft Bioelectronics secondary market activity?
Caplight tracks bids, offers, and trades in Neurosoft Bioelectronics's shares on secondary markets.